Cargando…
Potential of artificial intelligence to accelerate diagnosis and drug discovery for COVID-19
The coronavirus disease (COVID-19) pandemic has caused havoc worldwide. The tests currently used to diagnose COVID-19 are based on real time reverse transcription polymerase chain reaction (RT-PCR), computed tomography medical imaging techniques and immunoassays. It takes 2 days to obtain results fr...
Autores principales: | Mikkili, Indira, Karlapudi, Abraham Peele, Venkateswarulu, T. C., Kodali, Vidya Prabhakar, Macamdas, Deepika Sri Singh, Sreerama, Krupanidhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500072/ https://www.ncbi.nlm.nih.gov/pubmed/34707924 http://dx.doi.org/10.7717/peerj.12073 |
Ejemplares similares
-
In Vitro Assessment of The Bioactive Compounds and Anticancer Potential of Citrus medica Leaf Extract
por: Indira, Mikkili, et al.
Publicado: (2023) -
In silico sgRNA tool design for CRISPR control of quorum sensing in Acinetobacter species
por: Karlapudi, Abraham Peele, et al.
Publicado: (2018) -
Screening of Ipomoea tuba Leaf Extract for Identification of Bioactive Compounds and Evaluation of Its in vitro Antiproliferative Activity Against MCF-7 and HeLa Cells
por: Venkateswarulu, Thirupati Chinna, et al.
Publicado: (2020) -
Perspective on the challenges and opportunities of accelerating drug discovery with artificial intelligence
por: Santa Maria, John P., et al.
Publicado: (2023) -
Antioxidant potential and optimization of production of extracellular polysaccharide by Acinetobacter indicus M6
por: Ravi Teja, Ch., et al.
Publicado: (2021)